科美诊断申请一种多针加样臂结构及全自动化学发光免疫分析仪专利，结构更加紧凑，占用空间更小

Group 1 - The core viewpoint of the news is that Kemei Boyang Diagnostic Technology (Shanghai) Co., Ltd. has applied for a patent for a multi-needle sampling arm structure and a fully automated chemiluminescence immunoassay analyzer, indicating innovation in diagnostic technology [1] - The patent application was filed on December 2023, with the publication number CN120142687A, showcasing the company's commitment to advancing medical diagnostic equipment [1] - The patent describes a compact structure that includes a sampling arm body, a reagent needle group, and a driving mechanism group, which allows for vertical arrangement and independent movement of the sampling needles, enhancing efficiency and reducing space occupation [1] Group 2 - Kemei Boyang Diagnostic Technology (Shanghai) Co., Ltd. was established in 2005, located in Shanghai, with a registered capital of 34.088364 million RMB, primarily engaged in the pharmaceutical manufacturing industry [2] - The company has made investments in one other enterprise, participated in 87 bidding projects, and holds 36 trademark records and 309 patent records, along with 126 administrative licenses [2] - Kemei Diagnostic Technology Co., Ltd. was founded in 2007 in Beijing, with a registered capital of 40.1108 million RMB, focusing on professional technical services [2] - This company has invested in three other enterprises, participated in 74 bidding projects, and possesses 360 trademark records and 467 patent records, along with 110 administrative licenses [2]